These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9079638)

  • 1. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor.
    Mueller SG; White JR; Schraw WP; Lam V; Richmond A
    J Biol Chem; 1997 Mar; 272(13):8207-14. PubMed ID: 9079638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells.
    Mueller SG; Schraw WP; Richmond A
    J Biol Chem; 1994 Jan; 269(3):1973-80. PubMed ID: 8294449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-X-C chemokine receptor desensitization mediated through ligand-enhanced receptor phosphorylation on serine residues.
    Richmond A; Mueller S; White JR; Schraw W
    Methods Enzymol; 1997; 288():3-15. PubMed ID: 9356983
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2.
    Richardson RM; Pridgen BC; Haribabu B; Snyderman R
    J Biol Chem; 2000 Mar; 275(13):9201-8. PubMed ID: 10734056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein kinase C enhances the phosphorylation of the type B interleukin-8 receptor and stimulates its degradation in non-hematopoietic cells.
    Mueller SG; Schraw WP; Richmond A
    J Biol Chem; 1995 May; 270(18):10439-48. PubMed ID: 7737978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
    Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma growth stimulatory activity signaling through the class II interleukin-8 receptor enhances the tyrosine phosphorylation of Crk-associated substrate, p130, and a 70-kilodalton protein.
    Schraw W; Richmond A
    Biochemistry; 1995 Oct; 34(42):13760-7. PubMed ID: 7577968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction.
    Yang W; Wang D; Richmond A
    J Biol Chem; 1999 Apr; 274(16):11328-33. PubMed ID: 10196223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB.
    Nilsson G; Mikovits JA; Metcalfe DD; Taub DD
    Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
    Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
    J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA; Sharma A; de Nardin E
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils.
    Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA
    Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins.
    Owen JD; Strieter R; Burdick M; Haghnegahdar H; Nanney L; Shattuck-Brandt R; Richmond A
    Int J Cancer; 1997 Sep; 73(1):94-103. PubMed ID: 9334815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine and chemokine receptor expression in keloid and normal fibroblasts.
    Nirodi CS; Devalaraja R; Nanney LB; Arrindell S; Russell S; Trupin J; Richmond A
    Wound Repair Regen; 2000; 8(5):371-82. PubMed ID: 11115149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2.
    Sanchez X; Suetomi K; Cousins-Hodges B; Horton JK; Navarro J
    J Immunol; 1998 Jan; 160(2):906-10. PubMed ID: 9551928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.